BACKGROUND: Acute admission to an intensive care unit (ICU) of cancer patients is considered with increasing frequency due to a better life expectancy and more aggressive therapies. The aim of this study was to determine the characteristics and outcomes of cancer patients with unplanned admissions to general ICUs, and to compare these with outcomes of critically ill patients without cancer. MATERIAL AND METHODS: All unplanned ICU admissions in the Netherlands collected in the National Intensive Care Evaluation registry between January 2007 and January 2011 were analyzed. RESULTS AND CONCLUSION: Of the 140,154 patients with unplanned ICU admission 10.9% had a malignancy. Medical cancer patients were more severely ill on ICU admission in comparison with medical non-cancer patients, as reflected by higher needs for mechanical ventilation (50.8% vs. 46.4%, p < 0.001) and vasopressors within 24 hours after admission (41.5% vs. 33.0%, p < 0.001), higher Acute Physiology and Chronic Health Evaluation (APACHE) IV scores (88.1 vs. 67.5, p < 0.001) and a longer ICU stay (5.1 vs. 4.6 days, p < 0.001). In contrast, surgical cancer patients only displayed a modestly higher APACHE IV score on admission when compared with non-cancer surgical patients, whereas the other afore mentioned parameters were lower in the surgical cancer patients group. In-hospital mortality was almost twice as high in medical cancer patients (40.6%) as in medical patients without cancer (23.7%). In-hospital mortality of surgical cancer patients (17.4%) was slightly higher than in patients without cancer (14.6%). These data indicate that unplanned ICU admission is associated with a high mortality in patients with cancer when admitted for medical reasons.
BACKGROUND: Acute admission to an intensive care unit (ICU) of cancerpatients is considered with increasing frequency due to a better life expectancy and more aggressive therapies. The aim of this study was to determine the characteristics and outcomes of cancerpatients with unplanned admissions to general ICUs, and to compare these with outcomes of critically illpatients without cancer. MATERIAL AND METHODS: All unplanned ICU admissions in the Netherlands collected in the National Intensive Care Evaluation registry between January 2007 and January 2011 were analyzed. RESULTS AND CONCLUSION: Of the 140,154 patients with unplanned ICU admission 10.9% had a malignancy. Medical cancerpatients were more severely ill on ICU admission in comparison with medical non-cancerpatients, as reflected by higher needs for mechanical ventilation (50.8% vs. 46.4%, p < 0.001) and vasopressors within 24 hours after admission (41.5% vs. 33.0%, p < 0.001), higher Acute Physiology and Chronic Health Evaluation (APACHE) IV scores (88.1 vs. 67.5, p < 0.001) and a longer ICU stay (5.1 vs. 4.6 days, p < 0.001). In contrast, surgical cancerpatients only displayed a modestly higher APACHE IV score on admission when compared with non-cancer surgical patients, whereas the other afore mentioned parameters were lower in the surgical cancerpatients group. In-hospital mortality was almost twice as high in medical cancerpatients (40.6%) as in medical patients without cancer (23.7%). In-hospital mortality of surgical cancerpatients (17.4%) was slightly higher than in patients without cancer (14.6%). These data indicate that unplanned ICU admission is associated with a high mortality in patients with cancer when admitted for medical reasons.
Authors: Frank Daniel Martos-Benítez; Andrés Soto-García; Anarelys Gutiérrez-Noyola Journal: J Cancer Res Clin Oncol Date: 2018-01-23 Impact factor: 4.553
Authors: Su Jin Heo; Gyuri Kim; Choong-Kun Lee; Kyung Soo Chung; Hye Jin Choi; Joohyuk Sohn; Soohyeon Lee Journal: Support Care Cancer Date: 2014-11-23 Impact factor: 3.603
Authors: Maarten van Vliet; Ilona W M Verburg; Mark van den Boogaard; Nicolette F de Keizer; Niels Peek; Nicole M A Blijlevens; Peter Pickkers Journal: Intensive Care Med Date: 2014-06-28 Impact factor: 17.440
Authors: Monique M E M Bos; Ilona W M Verburg; Ineke Dumaij; Jacqueline Stouthard; Johannes W R Nortier; Dick Richel; Eric P A van der Zwan; Nicolette F de Keizer; Evert de Jonge Journal: Cancer Med Date: 2015-04-18 Impact factor: 4.452